Within the framework of BORGES, ESR14 will develop label-free sensing platforms for inflammatory biomarkers in multiple sclerosis. In particular, ESR14 will perform research oriented to immunology and neurology, aimed at validating the use of biosensors developed also within the BORGES consortium as ultrasensitive analytical tool for detection of MS biomarkers in cerebrospinal fluid and at identifying novel biomarkers for MS in CSF.

Host institution
Linköping University
Jan Ernerudh

The selection process for this position is now closed.

The position has been assigned to Sara Hojjati.